Part 601 - Licensing (BLA)

Part 601 of Title 21 of the Code of Federal Regulations outlines the FDA's licensing process for biologics, detailing the submission, review, and approval of Biologics License Applications. It specifies the requirements for product safety, efficacy, labeling, and post-approval reporting, and sets the procedural rules for granting, amending, or revoking biologics licenses.